XML 54 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefit Plans (Tables)
12 Months Ended
Jan. 01, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Allocated Employee Stock-Based Compensation Expense
We allocated the stock-based compensation expense for our equity incentive plans and our ESPP as follows (in thousands):
 
Year Ended December 31,
 
202020192018
Research and development$37,198 $19,374 $13,115 
Selling, general and administrative67,872 37,228 27,511 
Total stock-based compensation expense$105,070 $56,602 $40,626 

 
Year Ended December 31,
 
202020192018
Stock options$19,863 $23,422 $18,896 
Restricted stock units35,675 26,056 19,569 
Performance stock units47,106 4,878 — 
ESPP2,426 2,246 2,161 
Total stock-based compensation expense$105,070 $56,602 $40,626 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value per share of stock options and ESPP purchases were as follows:
 
Year Ended December 31,
 
202020192018
Stock options, including PSOs$9.44 $8.19 $9.07 
ESPP$6.12 $4.85 $6.40 
Schedule of Fair Value of Employee Share-Based Payments Awards Stock Option Assumptions and Weighted Average Fair Values
The grant-date fair value of stock option grants, including PSOs, and ESPP purchases was estimated using the following assumptions:
 
Year Ended December 31,
 
202020192018
Stock options, including PSOs:
Risk-free interest rate0.30 %1.77 %2.81 %
Dividend yield— %— %— %
Volatility54 %48 %55 %
Expected life4.4 years4.3 years4.4 years
ESPP:
Risk-free interest rate0.79 %2.16 %1.93 %
Dividend yield— %— %— %
Volatility52 %50 %53 %
Expected life6 months6 months6 months
Schedule of Fair Value of Employee Share-Based Payments Awards ESPP Assumptions and Weighted Average Fair Values
The grant-date fair value of stock option grants, including PSOs, and ESPP purchases was estimated using the following assumptions:
 
Year Ended December 31,
 
202020192018
Stock options, including PSOs:
Risk-free interest rate0.30 %1.77 %2.81 %
Dividend yield— %— %— %
Volatility54 %48 %55 %
Expected life4.4 years4.3 years4.4 years
ESPP:
Risk-free interest rate0.79 %2.16 %1.93 %
Dividend yield— %— %— %
Volatility52 %50 %53 %
Expected life6 months6 months6 months
Summary of All Stock Option Activity
Activity for stock options, including PSOs, during the year ended December 31, 2020 was as follows (in thousands, except per share amounts):
Shares
Weighted 
Average
Exercise Price
Weighted 
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Stock options outstanding at December 31, 201920,443 $9.91 
Granted1,637 $21.89 
Exercised(5,633)$4.77 
Cancelled(318)$20.12 
Stock options outstanding at December 31, 202016,129 $12.72 3.1 years$131,729 
Stock options exercisable at December 31, 202012,656 $10.47 2.5 years$128,740 
Summary of All RSU Activity Activity for RSUs during the year ended December 31, 2020 was as follows (in thousands, except per share amounts):
Shares
Weighted 
Average
Grant Date
Fair Value
Weighted 
Average
Remaining
Contractual 
Term
Aggregate
Intrinsic
Value
RSUs outstanding at December 31, 20194,422 $19.30 
Awarded3,053 $23.49 
Vested and released(1,699)$18.20 
Forfeited(398)$20.25 
RSUs outstanding at December 31, 20205,378 $21.96 1.9 years$107,933 
Activity for PSUs, during the year ended December 31, 2020 was as follows (in thousands, except per share amounts):
Shares
Weighted 
Average
Grant Date
Fair Value
Weighted 
Average
Remaining
Contractual 
Term
Aggregate
Intrinsic
Value
PSUs outstanding at December 31, 20194,379 $19.33 
Awarded4,656 $23.15 
Vested and released(1,529)$19.39 
Forfeited(128)$21.09 
PSUs outstanding at December 31, 20207,378 $21.70 3.5 years$148,076